V

Vaxart
D

VXRT

0.61260
USD
0.00
(0.79%)
Market Closed
Volume
6,166
EPS
-0
Div Yield
-
P/E
-2
Market Cap
139,354,132
OverviewSignalsIdeasNews
Related Instruments
    A
    APDN
    -0.00470
    (-2.55%)
    0.17970 USD
    AZN
    AZN
    0.950
    (1.47%)
    65.370 USD
    BNTX
    BNTX
    1.810
    (1.63%)
    113.050 USD
    C
    CODX
    0.00330
    (0.45%)
    0.73000 USD
    I
    INO
    -0.01000
    (-0.54%)
    1.83000 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    V
    VIR
    0.00000
    (0.00%)
    7.35000 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Vaxart

Sector: Healthcare
Industry: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.